[1]
S. Güleç Yılmaz, “The Role of Kallikrein10 (KLK10) Polymorphism in Prostate Cancer Susceptibility: KLK10 polymorphism in Prostate Cancer”, Urol J, vol. 19, no. 01, pp. 41–44, May 2021.